NCT00397358

Effect of Extraneal (Icodextrin)on Triglyceride Levels in PD Patients

Open-label Study to Evaluate the Effects of Once Daily Extraneal (7.5% Icodextrin) Peritoneal Dialysis Solution on Triglyceride Levels in Peritoneal Dialysis Patients

• Status: Withdrawn
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 0 (actual)
• Sponsor: Vantive Health LLC · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

This is a Phase IV study evaluating triglyceride levels in peritoneal dialysis patients.

Detailed description

This prospective, open label, multi-center study evaluates the use of 7.5% icodextrin used in the long-dwell exchange in peritoneal dialysis patients with elevated triglyceride levels. Fasting triglyceride levels will be measured during the study.

Conditions

• Peritoneal Dialysis
• Hypertriglyceridemia

Interventions

Type	Name	Description
DRUG	Extraneal (7.5% icodextrin) Peritoneal Dialysis Solution

Timeline

• Start date: 2006-11-01
• Primary completion: 2007-06-01
• Completion: 2007-06-01
• First posted: 2006-11-09
• Last updated: 2025-03-03

Locations

3 sites across 1 country: United States